Table 1.

Outcomes in 40 breast cancer patients undergoing COS for fertility preservation prior to neoadjuvant chemotherapy

Parameter	All patients (n = 40)	IFP (n = 11)	LFP (n = 10)	LP (n = 19)	P-value
Age (years)	30.43 ±4.25	30.73 ±3.52	31 ±5.25	29.95 ±4.24	0.697
Collected oocytes	11.78 ±9.12	9.18±6.0	10.90±10.77	13.74±9.67	0.173
Vitrified Oocytes	9.72 ±7.36	8.27 ±5.37	7.90±6.44	11.53 ±8.61	0.331
Days of stimulation	10.03 ±0.33	10.00 ±1.41	9.70±0.49	10.21 ±1.23	0.653
FSH/hMG total dose (IU)	2,540 ±713.1	2,677 ±544.3	2,260±706.6	2608 ±792.2	0.983
Estradiol Levels (pg/ml)	623.1 ±441.2	783.0 ±411.7	661.7 ±666.7	510.2 ±274.8	0.053

Data are expressed as mean ± SD.

IFP – initial follicular phase; LFP – late follicular phase; LP – luteal phase

The limit of significance is a p value ≤ 0.05